Impact of interventionalist's experience and gender on radiation dose and procedural time in CT-guided interventions-a retrospective analysis of 4380 cases over 10 years.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 28 04 2020
accepted: 12 08 2020
revised: 30 06 2020
pubmed: 28 8 2020
medline: 15 4 2021
entrez: 28 8 2020
Statut: ppublish

Résumé

To investigate the impact of the interventionalist's experience and gender on radiation dose and procedural time in CT-guided interventions. We retrospectively analyzed 4380 CT-guided interventions performed at our institution with the same CT scanner from 2009 until 2018, 1287 (29%) by female and 3093 (71%) by male interventionalists. Radiation dose, number of CT fluoroscopy images taken per intervention, total procedural time, type of intervention, and degree of difficulty were derived from the saved dose reports and images. All 16 interventionalists included in this analysis performed their first CT-guided interventions during the study period, and interventions performed by each interventionalist were counted to assess the level of experience for each intervention in terms of the number of prior interventions performed by her or him. The Mann-Whitney U test (MWU test), multivariate regression, and linear mixed model analysis were performed. Assessment of the impact of gender with the MWU test revealed that female interventionalists took a significantly smaller number of images (p < 0.0001) and achieved a lower dose-length product per intervention (p < 0.0001) while taking more time per intervention (p = 0.0001). This finding was confirmed for most types of interventions when additionally accounting for other possible impact factors in multivariate regression analysis. In linear mixed model analysis, we found that radiation dose, number of images taken per intervention, and procedural time decreased statistically significantly with interventionalist's experience. Radiation doses of CT-guided interventions are reduced by interventionalist's experience and, for most types of interventions, when performed by female interventionalists. • Radiation doses in CT-guided interventions are lower when performed by female interventionalists. • Procedural times of CT-guided interventions are longer when performed by female interventionalists. • Radiation doses of CT-guided interventions decrease with the interventionalist's experience.

Identifiants

pubmed: 32851446
doi: 10.1007/s00330-020-07185-x
pii: 10.1007/s00330-020-07185-x
pmc: PMC8263432
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

569-579

Commentaires et corrections

Type : ErratumIn

Références

Radiat Prot Dosimetry. 2016 Dec;172(4):475-482
pubmed: 26822419
Rofo. 2007 Mar;179(3):261-7
pubmed: 17262242
PLoS One. 2014 Oct 31;9(10):e111499
pubmed: 25360767
J Am Coll Radiol. 2015 Jan;12(1):82-9
pubmed: 25086959
Radiology. 2001 May;219(2):515-20
pubmed: 11323481
AJR Am J Roentgenol. 2007 May;188(5):1187-94
pubmed: 17449757
Br J Radiol. 2019 Jul;92(1099):20180937
pubmed: 31045438
J Vasc Surg. 2013 Sep;58(3):702-9
pubmed: 23810300
Radiology. 1998 Feb;206(2):429-35
pubmed: 9457196
Acta Radiol. 2020 Jan;61(1):110-116
pubmed: 31154801
Br J Radiol. 1997 May;70(833):498-503
pubmed: 9227232
Br J Radiol. 1998 Sep;71(849):954-60
pubmed: 10195011
Ann Surg. 2005 Jul;242(1):83-91
pubmed: 15973105
Radiology. 2001 Jul;220(1):161-7
pubmed: 11425990
Radiat Environ Biophys. 2019 Aug;58(3):373-384
pubmed: 30993431
Acad Radiol. 2014 Jul;21(7):869-78
pubmed: 24713540
J Am Coll Radiol. 2014 Mar;11(3):279-84
pubmed: 24424426
Acad Radiol. 2015 May;22(5):668-73
pubmed: 25863793
Eur Radiol. 2020 Mar;30(3):1564-1570
pubmed: 31712962
AJR Am J Roentgenol. 2011 Jul;197(1):W97-103
pubmed: 21701002
Cardiovasc Intervent Radiol. 2015 Aug;38(4):871-7
pubmed: 25522982
Acta Radiol. 2014 Feb;55(1):86-90
pubmed: 23884839
J Vasc Interv Radiol. 2010 Jul;21(7):969-75
pubmed: 20304676
Radiographics. 2012 Jul-Aug;32(4):1109-19; discussion 1119-20
pubmed: 22786997
J Am Coll Radiol. 2013 Nov;10(11):840-6
pubmed: 24183553
Radiol Bras. 2017 May-Jun;50(3):162-169
pubmed: 28670027
Radiology. 2000 Jul;216(1):180-4
pubmed: 10887246

Auteurs

Dorothea Theilig (D)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Diagnostic and Interventional Radiology, Augustenburger Platz 1, 13353, Berlin, Germany. dorothea.theilig@charite.de.

Anna Mayerhofer (A)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Diagnostic and Interventional Radiology, Augustenburger Platz 1, 13353, Berlin, Germany.

David Petschelt (D)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Diagnostic and Interventional Radiology, Augustenburger Platz 1, 13353, Berlin, Germany.

Aboelyazid Elkilany (A)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Diagnostic and Interventional Radiology, Augustenburger Platz 1, 13353, Berlin, Germany.

Bernd Hamm (B)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Diagnostic and Interventional Radiology, Augustenburger Platz 1, 13353, Berlin, Germany.

Bernhard Gebauer (B)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Diagnostic and Interventional Radiology, Augustenburger Platz 1, 13353, Berlin, Germany.

Dominik Geisel (D)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Diagnostic and Interventional Radiology, Augustenburger Platz 1, 13353, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH